vs

Side-by-side financial comparison of MADRIGAL PHARMACEUTICALS, INC. (MDGL) and Mueller Water Products, Inc. (MWA). Click either name above to swap in a different company.

MADRIGAL PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($321.1M vs $318.2M, roughly 1.0× Mueller Water Products, Inc.). Mueller Water Products, Inc. runs the higher net margin — 13.6% vs -18.2%, a 31.8% gap on every dollar of revenue. On growth, MADRIGAL PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (210.8% vs 4.6%). Mueller Water Products, Inc. produced more free cash flow last quarter ($44.0M vs $-133.8M).

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.

Mueller Water Products, Inc. (MWP) is a publicly traded company headquartered in Atlanta, Georgia. It is one of the largest manufacturers and distributors of fire hydrants, gate valves, and other water infrastructure products in North America. MWP is made up of two business units—Mueller Co. and Mueller Technologies—that oversee more than a dozen brands and affiliates, including Echologics and Mueller Systems.

MDGL vs MWA — Head-to-Head

Bigger by revenue
MDGL
MDGL
1.0× larger
MDGL
$321.1M
$318.2M
MWA
Growing faster (revenue YoY)
MDGL
MDGL
+206.2% gap
MDGL
210.8%
4.6%
MWA
Higher net margin
MWA
MWA
31.8% more per $
MWA
13.6%
-18.2%
MDGL
More free cash flow
MWA
MWA
$177.8M more FCF
MWA
$44.0M
$-133.8M
MDGL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MDGL
MDGL
MWA
MWA
Revenue
$321.1M
$318.2M
Net Profit
$-58.6M
$43.2M
Gross Margin
37.6%
Operating Margin
-18.6%
17.8%
Net Margin
-18.2%
13.6%
Revenue YoY
210.8%
4.6%
Net Profit YoY
1.4%
22.4%
EPS (diluted)
$-2.55
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MDGL
MDGL
MWA
MWA
Q4 25
$321.1M
$318.2M
Q3 25
$287.3M
$380.8M
Q2 25
$212.8M
$380.3M
Q1 25
$137.3M
$364.3M
Q4 24
$103.3M
$304.3M
Q3 24
$62.2M
$348.2M
Q2 24
$356.7M
Q1 24
$0
$353.4M
Net Profit
MDGL
MDGL
MWA
MWA
Q4 25
$-58.6M
$43.2M
Q3 25
$-114.2M
$52.6M
Q2 25
$-42.3M
$52.5M
Q1 25
$-73.2M
$51.3M
Q4 24
$-59.4M
$35.3M
Q3 24
$-107.0M
$10.0M
Q2 24
$47.3M
Q1 24
$-147.5M
$44.3M
Gross Margin
MDGL
MDGL
MWA
MWA
Q4 25
37.6%
Q3 25
36.8%
Q2 25
38.3%
Q1 25
96.7%
35.1%
Q4 24
33.8%
Q3 24
31.8%
Q2 24
36.8%
Q1 24
36.9%
Operating Margin
MDGL
MDGL
MWA
MWA
Q4 25
-18.6%
17.8%
Q3 25
-39.7%
18.3%
Q2 25
-22.2%
19.4%
Q1 25
-57.8%
19.2%
Q4 24
-64.8%
15.6%
Q3 24
-187.1%
8.2%
Q2 24
18.8%
Q1 24
18.0%
Net Margin
MDGL
MDGL
MWA
MWA
Q4 25
-18.2%
13.6%
Q3 25
-39.8%
13.8%
Q2 25
-19.9%
13.8%
Q1 25
-53.4%
14.1%
Q4 24
-57.5%
11.6%
Q3 24
-172.0%
2.9%
Q2 24
13.3%
Q1 24
12.5%
EPS (diluted)
MDGL
MDGL
MWA
MWA
Q4 25
$-2.55
$0.27
Q3 25
$-5.08
$0.34
Q2 25
$-1.90
$0.33
Q1 25
$-3.32
$0.33
Q4 24
$-2.50
$0.22
Q3 24
$-4.92
$0.07
Q2 24
$0.30
Q1 24
$-7.38
$0.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MDGL
MDGL
MWA
MWA
Cash + ST InvestmentsLiquidity on hand
$198.7M
Total DebtLower is stronger
$339.9M
Stockholders' EquityBook value
$602.7M
$1.0B
Total Assets
$1.3B
$1.8B
Debt / EquityLower = less leverage
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MDGL
MDGL
MWA
MWA
Q4 25
$198.7M
Q3 25
$295.7M
Q2 25
$186.2M
Q1 25
$183.6M
Q4 24
$100.0M
Q3 24
$232.7M
Q2 24
Q1 24
$622.5M
Total Debt
MDGL
MDGL
MWA
MWA
Q4 25
$339.9M
Q3 25
$339.8M
Q2 25
$118.4M
Q1 25
$118.0M
Q4 24
$117.6M
Q3 24
$117.1M
Q2 24
Q1 24
$116.1M
Stockholders' Equity
MDGL
MDGL
MWA
MWA
Q4 25
$602.7M
$1.0B
Q3 25
$625.7M
$981.7M
Q2 25
$696.0M
$929.0M
Q1 25
$710.6M
$873.6M
Q4 24
$754.4M
$834.1M
Q3 24
$777.2M
$810.1M
Q2 24
$791.6M
Q1 24
$850.8M
$754.5M
Total Assets
MDGL
MDGL
MWA
MWA
Q4 25
$1.3B
$1.8B
Q3 25
$1.4B
$1.8B
Q2 25
$1.0B
$1.7B
Q1 25
$996.6M
$1.7B
Q4 24
$1.0B
$1.6B
Q3 24
$1.1B
$1.6B
Q2 24
$1.6B
Q1 24
$1.1B
$1.5B
Debt / Equity
MDGL
MDGL
MWA
MWA
Q4 25
0.56×
Q3 25
0.54×
Q2 25
0.17×
Q1 25
0.17×
Q4 24
0.16×
Q3 24
0.15×
Q2 24
Q1 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MDGL
MDGL
MWA
MWA
Operating Cash FlowLast quarter
$-133.5M
$61.2M
Free Cash FlowOCF − Capex
$-133.8M
$44.0M
FCF MarginFCF / Revenue
-41.7%
13.8%
Capex IntensityCapex / Revenue
0.1%
5.4%
Cash ConversionOCF / Net Profit
1.42×
TTM Free Cash FlowTrailing 4 quarters
$173.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MDGL
MDGL
MWA
MWA
Q4 25
$-133.5M
$61.2M
Q3 25
$79.8M
$83.5M
Q2 25
$-47.1M
$67.4M
Q1 25
$-88.9M
$14.3M
Q4 24
$-104.5M
$54.1M
Q3 24
$-67.0M
$89.3M
Q2 24
$87.3M
Q1 24
$-149.2M
$-5.7M
Free Cash Flow
MDGL
MDGL
MWA
MWA
Q4 25
$-133.8M
$44.0M
Q3 25
$79.0M
$69.0M
Q2 25
$55.7M
Q1 25
$5.1M
Q4 24
$-104.7M
$42.2M
Q3 24
$-67.8M
$69.9M
Q2 24
$75.1M
Q1 24
$-149.5M
$-15.8M
FCF Margin
MDGL
MDGL
MWA
MWA
Q4 25
-41.7%
13.8%
Q3 25
27.5%
18.1%
Q2 25
14.6%
Q1 25
1.4%
Q4 24
-101.3%
13.9%
Q3 24
-109.0%
20.1%
Q2 24
21.1%
Q1 24
-4.5%
Capex Intensity
MDGL
MDGL
MWA
MWA
Q4 25
0.1%
5.4%
Q3 25
0.3%
3.8%
Q2 25
0.0%
3.1%
Q1 25
0.0%
2.5%
Q4 24
0.2%
3.9%
Q3 24
1.3%
5.6%
Q2 24
3.4%
Q1 24
2.9%
Cash Conversion
MDGL
MDGL
MWA
MWA
Q4 25
1.42×
Q3 25
1.59×
Q2 25
1.28×
Q1 25
0.28×
Q4 24
1.53×
Q3 24
8.93×
Q2 24
1.85×
Q1 24
-0.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MDGL
MDGL

Rebates Customer Fees Credits Co Pay Assistance And Other$208.5M65%
Other$76.0M24%
Chargebacks Discounts For Prompt Pay And Other Allowances$36.6M11%

MWA
MWA

Water Flow Solutions$173.0M54%
Water Management Solutions$145.2M46%

Related Comparisons